The two cytosine to thymidine single-point mutations in the TERT proximal promoter (− 146 and − 124 bp from the translation start site), recurrent in several cancers, were found to create a de novo consensus binding motif for ETS transcription factor family [78–83]. The gene discussed is TERT; the disease is cancer.